Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Expert Opinion on Investigational Drugs
|
May 1, 2013
Vercirnon for the treatment of Crohn's disease
Kristen O Arseneau, Fabio Cominelli
Gut Microbes
|
March 19, 2014
Functional defects in NOD2 signaling in experimental and human Crohn disease
Daniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Current Opinion in Gastroenterology
|
September 14, 2017
Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine
Giorgos Bamias, Kristen O Arseneau, Fabio Cominelli
Expert Opinion on Biological Therapy
|
August 24, 2017
Natalizumab in the treatment of Crohn's disease patients
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli
Expert Opinion on Drug Safety
|
November 18, 2014
Safety considerations when using anti-TNFα therapy to treat Crohn's disease
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli
Current Opinion in Gastroenterology
|
September 10, 2014
Cytokines and mucosal immunity
Giorgos Bamias, Kristen O Arseneau, Fabio Cominelli
Immunology Letters
|
June 19, 2014
Inflammatory bowel disease
Daniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 16, 2004
Effect of digestive health care services integration on resource use and outcomes in patients with digestive disorders
Kristen O Arseneau, Paul Yeaton, Michel Kahaleh, et al.
Trends in Molecular Medicine
|
May 24, 2003
Mouse models for the study of Crohn's disease
Theresa T Pizarro, Kristen O Arseneau, Giorgos Bamias, et al.
Current Gastroenterology Reports
|
April 2, 2008
Innate and adaptive immune responses related to IBD pathogenesis
Kristen O Arseneau, Hiroshi Tamagawa, Theresa T Pizarro, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Expert Opinion on Investigational Drugs
|
May 1, 2013
Vercirnon for the treatment of Crohn's disease
Kristen O Arseneau, Fabio Cominelli
Gut Microbes
|
March 19, 2014
Functional defects in NOD2 signaling in experimental and human Crohn disease
Daniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Current Opinion in Gastroenterology
|
September 14, 2017
Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine
Giorgos Bamias, Kristen O Arseneau, Fabio Cominelli
Expert Opinion on Biological Therapy
|
August 24, 2017
Natalizumab in the treatment of Crohn's disease patients
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli
Expert Opinion on Drug Safety
|
November 18, 2014
Safety considerations when using anti-TNFα therapy to treat Crohn's disease
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli
Current Opinion in Gastroenterology
|
September 10, 2014
Cytokines and mucosal immunity
Giorgos Bamias, Kristen O Arseneau, Fabio Cominelli
Immunology Letters
|
June 19, 2014
Inflammatory bowel disease
Daniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 16, 2004
Effect of digestive health care services integration on resource use and outcomes in patients with digestive disorders
Kristen O Arseneau, Paul Yeaton, Michel Kahaleh, et al.
Trends in Molecular Medicine
|
May 24, 2003
Mouse models for the study of Crohn's disease
Theresa T Pizarro, Kristen O Arseneau, Giorgos Bamias, et al.
Current Gastroenterology Reports
|
April 2, 2008
Innate and adaptive immune responses related to IBD pathogenesis
Kristen O Arseneau, Hiroshi Tamagawa, Theresa T Pizarro, et al.
Page
of 3